It would dovetail very nicely with their Sigma-Aldrich purchase, and is eminently do-able.
Not my favored scenario; just makes sense. My guess is they would pay $85 -$92/share.
Solid & broad patent portfolio, uninspired/weak share price, lots of cash suggests that OLED is likely to draw suitors. Aging management likely to be receptive when weighing the risks of what many view as a topping market.I would not be surprised to see a bid for OLED ahead of the election. A prospective suitor won't wait until OLED is firing on all cylinders.
Mea culpa! I based my comment on numbers provided without proper context. Congratulations to NEO on their continued outstanding performance! Again, my apologies for previous & hasty post.
For those of you who follow medical/biotech area, you might want to take a look at NEO. Rapidly growing
diagnostic lab (cancer) company that is firing on all cylinders & largely unknown at the retail level. Compelling story. As always, conduct your own due diligence & come to your own conclusions.
Question: Why would 1st Eagle maintain this losing position for so long? it simply doesn't make sense. It makes me wonder whether the shares are actually "parked" in the fund & controlled indirectly by Roche family as an investment vehicle. On the other hand, why did Fidelity belatedly come to the table? Weird; very weird.
supplying OLED iPhone screens to Apple. "Happy-Talk" on QDOT is just that; they simply can't deliver on OLED TV at this time (and will go full bore to prevent LG or Japan Display from eroding their supply relationship with Apple). They're just putting the best face that they can on their inability to compete in OLED TV at this time.
You likee eat kitty cat? How you say meow, meow? You no likee OLED ("OREDD") at $72.00? So sollee, so vely sollee. Me likee velly muchlee.